A detailed history of Guggenheim Capital LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 38,293 shares of TMO stock, worth $20.1 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
38,293
Previous 37,157 3.06%
Holding current value
$20.1 Million
Previous $20.5 Million 15.27%
% of portfolio
0.17%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$531.86 - $624.21 $604,192 - $709,102
1,136 Added 3.06%
38,293 $23.7 Million
Q2 2024

Aug 14, 2024

SELL
$541.52 - $599.02 $161,372 - $178,507
-298 Reduced 0.8%
37,157 $20.5 Million
Q1 2024

May 14, 2024

BUY
$528.82 - $599.43 $76,150 - $86,317
144 Added 0.39%
37,455 $21.8 Million
Q4 2023

Feb 14, 2024

BUY
$431.41 - $532.94 $967,221 - $1.19 Million
2,242 Added 6.39%
37,311 $19.8 Million
Q3 2023

Nov 14, 2023

SELL
$498.29 - $574.41 $1.02 Million - $1.18 Million
-2,053 Reduced 5.53%
35,069 $17.8 Million
Q2 2023

Aug 11, 2023

BUY
$508.46 - $591.13 $1.96 Million - $2.27 Million
3,847 Added 11.56%
37,122 $19.4 Million
Q1 2023

May 10, 2023

BUY
$535.0 - $604.82 $3.33 Million - $3.77 Million
6,227 Added 23.02%
33,275 $19.2 Million
Q4 2022

Feb 14, 2023

BUY
$484.71 - $571.37 $2.08 Million - $2.45 Million
4,285 Added 18.82%
27,048 $14.9 Million
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $1.51 Million - $1.8 Million
-2,979 Reduced 11.57%
22,763 $11.5 Million
Q2 2022

Aug 15, 2022

SELL
$500.9 - $612.21 $2.71 Million - $3.31 Million
-5,406 Reduced 17.36%
25,742 $14 Million
Q1 2022

May 16, 2022

SELL
$524.0 - $644.92 $12.5 Million - $15.4 Million
-23,858 Reduced 43.37%
31,148 $18.4 Million
Q4 2021

Feb 14, 2022

BUY
$569.0 - $667.24 $5.96 Million - $6.99 Million
10,477 Added 23.53%
55,006 $36.7 Million
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $3.17 Million - $3.8 Million
-6,228 Reduced 12.27%
44,529 $25.4 Million
Q2 2021

Aug 13, 2021

SELL
$441.0 - $508.24 $1.45 Million - $1.68 Million
-3,298 Reduced 6.1%
50,757 $25.6 Million
Q1 2021

May 13, 2021

SELL
$439.85 - $518.83 $2.51 Million - $2.96 Million
-5,697 Reduced 9.53%
54,055 $24.7 Million
Q4 2020

Feb 16, 2021

BUY
$435.06 - $527.66 $1.18 Million - $1.43 Million
2,714 Added 4.76%
59,752 $27.8 Million
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $465,902 - $571,768
-1,295 Reduced 2.22%
57,038 $25.2 Million
Q2 2020

Aug 14, 2020

SELL
$275.2 - $362.34 $1.31 Million - $1.73 Million
-4,764 Reduced 7.55%
58,333 $21.1 Million
Q1 2020

Jun 02, 2020

SELL
$255.3 - $340.05 $580,552 - $773,273
-2,274 Reduced 3.48%
63,097 $17.9 Million
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $3.08 Million - $3.72 Million
-11,341 Reduced 14.78%
65,371 $21.2 Million
Q3 2019

Nov 14, 2019

SELL
$268.46 - $305.43 $3.65 Million - $4.15 Million
-13,601 Reduced 15.06%
76,712 $22.3 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $2.05 Million - $2.36 Million
-7,972 Reduced 8.11%
90,313 $26.5 Million
Q1 2019

May 15, 2019

SELL
$212.17 - $273.72 $2.2 Million - $2.83 Million
-10,357 Reduced 9.53%
98,285 $26.9 Million
Q4 2018

Feb 14, 2019

SELL
$208.47 - $251.98 $100,899 - $121,958
-484 Reduced 0.44%
108,642 $24.3 Million
Q3 2018

Nov 14, 2018

BUY
$205.57 - $244.32 $275,463 - $327,388
1,340 Added 1.24%
109,126 $26.6 Million
Q2 2018

Aug 14, 2018

SELL
$203.14 - $219.53 $33.4 Million - $36.1 Million
-164,593 Reduced 60.43%
107,786 $22.3 Million
Q1 2018

May 15, 2018

SELL
$192.98 - $224.11 $8.31 Million - $9.66 Million
-43,082 Reduced 13.66%
272,379 $56.2 Million
Q4 2017

Feb 14, 2018

BUY
$182.03 - $200.37 $3.19 Million - $3.52 Million
17,552 Added 5.89%
315,461 $59.9 Million
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $51.2 Million - $57.8 Million
297,909
297,909 $56.4 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.